Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
DiD (DiDC 18 (5)): Optimizing Cell Membrane Staining Workflo
2026-06-27
DiD (DiDC 18 (5)) redefines high-contrast cell membrane staining and tracking—even in demanding, autofluorescent, or inflamed tissue models. Discover how to leverage this red fluorescent probe for robust neuronal tracing, cell migration assays, and immunofluorescence, drawing on proven protocols and recent breakthroughs.
-
Phosphotungstic Acid Negative Stain Solution: Elevating Vira
2026-06-26
Phosphotungstic Acid Negative Stain Solution (2%) empowers electron microscopists to reveal intricate viral and macromolecular structures, accelerating antiviral research. Its ready-to-use formulation and optimized protocol parameters streamline workflows, while recent glycan-targeting breakthroughs highlight its pivotal role in next-generation virology.
-
EMSCs Modulate Microglial Polarization via NF-κB/MAPK After
2026-06-26
This study demonstrates that transplantation of ectomesenchymal stem cells (EMSCs) from the nasal mucosa can drive microglial polarization toward an anti-inflammatory phenotype and enhance IL-10 secretion in a mouse model of intracerebral hemorrhage (ICH). The findings provide mechanistic insight that EMSC-mediated neuroprotection operates through inhibition of the NF-κB and MAPK signaling pathways, suggesting new directions for hemorrhagic stroke therapy.
-
Selective Autophagy Regulates IRF3 Stability in Antiviral Im
2026-06-25
The referenced study uncovers the mechanism by which selective autophagy, mediated by CALCOCO2/NDP52 and regulated by the deubiquitinase PSMD14, controls the stability of the transcription factor IRF3 during antiviral responses. These findings reveal a new layer of regulation balancing type I interferon production and immune suppression, offering important implications for innate immune research.
-
Dihydrotestosterone (DHT): Reliable AR & EGFR Signaling for
2026-06-25
This scenario-driven guide explores how Dihydrotestosterone (DHT, SKU B8214) addresses core challenges in androgen receptor and growth factor pathway research. With a focus on reproducibility, sensitivity, and robust data interpretation, the article offers actionable laboratory insight for biomedical researchers leveraging DHT in cell signaling, viability, and translational disease models.
-
Z-IETD-FMK: Caspase-8 Inhibition for Apoptosis & T Cell Stud
2026-06-24
Z-IETD-FMK (Benzyloxycarbonyl-Ile-Glu(OMe)-Thr-Asp(OMe)-fluoromethylketone) empowers precise, context-specific inhibition of caspase-8, unlocking mechanistic insights in immune cell activation and apoptosis research. Its unique selectivity and robust protocol flexibility enable advanced dissection of T cell proliferation and apoptotic signaling, even in complex disease models.
-
Purifying HLA-G+ EVT for Immune Tolerance Studies in Human P
2026-06-23
This study presents a robust protocol for isolating highly pure HLA-G+ extravillous trophoblasts (EVT) from human term placental tissue, enabling detailed immunophenotyping and functional analyses. The approach overcomes past limitations of cell line and organoid models, offering a reproducible platform to investigate maternal-fetal immune interactions and their relevance to pregnancy health and pathology.
-
Broad-Spectrum Bivalent mRNA Vaccine Neutralizes SARS-CoV-2
2026-06-23
The reference study introduces RQ3025, a bivalent mRNA vaccine designed to induce robust, broad-spectrum immunity against diverse SARS-CoV-2 variants, including recent Omicron sublineages. This preclinical evaluation demonstrates superior neutralizing antibody responses and Th1-biased cellular immunity, offering insight into future vaccine strategies for evolving viral threats.
-
Crystal Violet Staining Solution: Enhancing Assay Precision
2026-06-22
Explore how Crystal Violet Staining Solution elevates nuclear staining dye precision in small tissue and cell-based assays. This article reveals scientific advances for optimizing quantification in challenging sample preparations, offering unique guidance beyond standard protocols.
-
Repurposing Lopinavir: Inhibition of MERS-CoV Replication in
2026-06-22
The study by de Wilde et al. systematically screened an FDA-approved drug library and identified Lopinavir as one of four compounds capable of inhibiting MERS-CoV replication in vitro. These findings highlight the translational potential of HIV protease inhibitors in emergent coronavirus research and offer a foundation for rapid therapeutic evaluation during outbreaks.
-
IL-36/IL-36R Axis and NETosis in Psoriasis: New Mechanistic
2026-06-21
This study uncovers how TLR and purinergic signaling drive neutrophil extracellular trap (NET) formation in psoriasis, highlighting the IL-36/IL-36R axis as a critical amplifier of skin inflammation. The findings offer a mechanistic foundation for targeting NETosis and IL-36 signaling in future therapeutic strategies.
-
Recombinant Human Oncostatin M: Precision Cytokine Workflows
2026-06-20
Recombinant Human Oncostatin M (E.coli, Tag Free, Lyophilized) elevates cell-based assays with unmatched purity and activity, empowering reliable cytokine stimulation and proliferation studies. This article delivers detailed protocols, advanced troubleshooting, and actionable insights for researchers seeking robust, reproducible cytokine-driven experiments.
-
iPSC-Derived Organoids Advance Pangenotype HEV Research
2026-06-19
This study demonstrates that iPSC-induced liver, intestinal, and brain organoids can sustain infection and replication of major hepatitis E virus (HEV) genotypes. The organoid models reveal tissue-specific HEV pathogenesis and support antiviral drug evaluation, offering a physiologically relevant alternative to traditional in vitro and animal models.
-
PURPL lncRNA Controls Senescence via H3K9me3 Epigenetic Sile
2026-06-19
Wang et al. identify PURPL, a nuclear long non-coding RNA, as a key epigenetic regulator of cellular senescence through H3K9me3-mediated gene silencing. CRISPRi-mediated depletion of PURPL rejuvenates senescent cells, pointing to new avenues for targeting age-related cellular dysfunction.
-
Hydroxychloroquine Sulfate: Technical Guide for Autoimmune R
2026-06-18
Hydroxychloroquine Sulfate (SKU B4874) addresses the need for precise modulation of autophagy and toll-like receptor signaling in autoimmune disease research, especially systemic lupus erythematosus and rheumatoid arthritis models. It is best suited for aqueous-based protocols with short-term solution use and is not appropriate for workflows requiring organic solvent solubility or long-term storage.